About 600 Sero-discordant couples
where one partner is HIV positive and the other is not will take part in a new
research study to help decide the best HIV Treatment Strategy that will reduce
the rate of infection in the population.
A study by the National Agency for
Control of AIDS (NACA) is to help decide whether health workers choose to
administer the anti-retroviral drug, Trvada- as a prevention or treatment for
HIV/AIDS.
Multiple studies have established
that anti-retroviral drugs could be used to reduce the rate of infection in a
population in two different ways, known by the acronyms PrEP (Pre-Exposure
Prophylis) and TasP (Treatment as Prevention).
Director General, National Agency
for
Control of AIDS (NACA), Prof. John Idoko disclosed that the study is being carried out in Nigeria to see if it will work under normal conditions.
“The whole idea is to see if it will
work so well in this situation, and if it does, it will become a policy. NACA
understands that, given the data and experience to be gained from the project,
it should be possible to present this to stakeholders for consideration as part
of policy and guidelines for the comprehensive combination preventing program
in the country.”
0 comments:
Post a Comment